Ocular cicatricial pemphigoid (immunologic studies).
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D001485:Basement Membrane / Q000276:immunology; D002610:Cheek / Q000276:immunology; D002921:Cicatrix / Q000150:complications / Q000276:immunology; D003165:Complement System Proteins / Q000032:analysis; D003228:Conjunctiva / Q000276:immunology; D003231:Conjunctivitis / Q000150:complications / Q000276:immunology*; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000150:complications; D009061:Mouth Mucosa / Q000276:immunology; D012867:Skin / Q000276:immunology; D012871:Skin Diseases / Q000150:complications; D012872:Skin Diseases, Vesiculobullous / Q000150:complications / Q000276:immunology*
D000906:Antibodies; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007136:Immunoglobulins; D003165:Complement System Proteins